Literature DB >> 19888658

Stability improvement of a liquid enzyme product.

Núria Jiménez1, Maria Luisa Garcia, Javier Galán, Alberto Vallet, Geoffrey Owen, G Michael Wall.   

Abstract

The shelf-life of a previously developed two-part liquid-liquid enzyme ceruminolytic product was improved maintaining the same final reconstituted composition and re-formulating the liquid enzyme portion as a drug granulate by a double wet granulation process. The critical steps for the preparation of the granulate were studied (mixing/granulating times and drying) determining the proteolytic activity, the residual ethanol, and the moisture content of the granulates. The original liquid-liquid formulation had been proven effective as a ceruminolytic agent, but only had stability of greater than 75% enzyme activity for up to 18 months and up to 1 day at room temperature after combining the two parts. The resulting improved product was proven to be stable for up to 24 months at 30 degrees C, and up to 3 days at room temperature after combining the two parts. Therefore, maintaining the enzyme in a granulated form until reconstitution afforded an improvement in stability compared with the original two-part liquid-liquid formulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19888658      PMCID: PMC2799593          DOI: 10.1208/s12249-009-9327-x

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  10 in total

1.  Influence of adjuvants on the dissolution profile of tablets containing high doses of spray-dried extract of Maytenus ilicifolia.

Authors:  T P de Souza; V L Bassani; G González Ortega; T C dalla Costa; P R Petrovick
Journal:  Pharmazie       Date:  2001-09       Impact factor: 1.267

2.  Development of a liquid enzyme-based ceruminolytic product.

Authors:  Nuria Jimenez; Marisa L Garcia; Javier Galan; Alberto Vallet; Geoffrey R Owen; G Michael Wall
Journal:  J Pharm Sci       Date:  2008-11       Impact factor: 3.534

3.  Impact milling of pharmaceutical agglomerates in the wet and dry states.

Authors:  Luke R Schenck; Russell V Plank
Journal:  Int J Pharm       Date:  2007-07-27       Impact factor: 5.875

4.  Dehydration-induced conformational transitions in proteins and their inhibition by stabilizers.

Authors:  S J Prestrelski; N Tedeschi; T Arakawa; J F Carpenter
Journal:  Biophys J       Date:  1993-08       Impact factor: 4.033

5.  Quantitation of the area of overlap between second-derivative amide I infrared spectra to determine the structural similarity of a protein in different states.

Authors:  B S Kendrick; A Dong; S D Allison; M C Manning; J F Carpenter
Journal:  J Pharm Sci       Date:  1996-02       Impact factor: 3.534

6.  Long-term and high-temperature storage of supercritically-processed microparticulate protein powders.

Authors:  M A Winters; P G Debenedetti; J Carey; H G Sparks; S U Sane; T M Przybycien
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

7.  Fourier-transform infrared spectroscopic investigation of protein stability in the lyophilized form.

Authors:  H R Costantino; K Griebenow; P Mishra; R Langer; A M Klibanov
Journal:  Biochim Biophys Acta       Date:  1995-11-15

Review 8.  The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation.

Authors:  J L Cleland; M F Powell; S J Shire
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1993       Impact factor: 4.889

Review 9.  Solid-phase aggregation of proteins under pharmaceutically relevant conditions.

Authors:  H R Costantino; R Langer; A M Klibanov
Journal:  J Pharm Sci       Date:  1994-12       Impact factor: 3.534

10.  Formation of microparticulate protein powder using a supercritical fluid antisolvent.

Authors:  S D Yeo; G B Lim; P G Debendetti; H Bernstein
Journal:  Biotechnol Bioeng       Date:  1993-02-05       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.